Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
Showing 8,561 - 8,580 results of 100,179 for search '(( 5 non decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.03s Refine Results
  1. 8561
    Image 5_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif

    Image 5_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif by Tyler W. Ferris (22481194)

    Published 2025
    “…The current study was conceived to evaluate the nutritional and biophysical characteristics of two sorghum lines with k1C family deletions compared to unedited RTx430. Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …”
    Save to List
    Saved in:
  2. 8562
    Intrathecal (i.t.) pre- or posttreatment with EphB1-Fc inhibited chronic constrictive injury (CCI)-induced neuropathic pain and spinal Fos protein expression, accompanied by the decreased expression of spinal PI3K-p110γ and phosphorylated AKT (p-AKT).

    Intrathecal (i.t.) pre- or posttreatment with EphB1-Fc inhibited chronic constrictive injury (CCI)-induced neuropathic pain and spinal Fos protein expression, accompanied by the de... by Li-Na Yu (312492)

    Published 2013
    “…<p>Consecutive intrathecal injection of EphB1-Fc on 1-h before CCI and 1-d and 2-d after CCI in the pre-treatment experiment and Intrathecal injection of a single dose of EphB1-Fc on 5-d after CCI in post-treatment experiment were performed. …”
    Save to List
    Saved in:
  3. 8563
    Amino acids variations in the Ksr1 protein sequence (including those at positions 189 and 272) across publicly available whole genome sequenced <i>C</i>. <i>albicans</i> isolates.

    Amino acids variations in the Ksr1 protein sequence (including those at positions 189 and 272) across publicly available whole genome sequenced <i>C</i>. <i>albicans</i> isolates. by Pétra Vande Zande (17628246)

    Published 2024
    Save to List
    Saved in:
  4. 8564
    Image_6_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_6_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  5. 8565
    Image_1_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_1_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  6. 8566
    Image_7_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_7_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  7. 8567
    Image_4_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_4_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  8. 8568
    Image_8_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_8_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  9. 8569
    Image_9_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_9_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  10. 8570
    Image_2_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_2_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  11. 8571
    Image_3_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF

    Image_3_A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins.TIF by Sarra El-Soussi (11228799)

    Published 2021
    “…The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. …”
    Save to List
    Saved in:
  12. 8572
    Comparison of the shadow index of blindfolded compound eyes with wild-type gravid mosquitoes.

    Comparison of the shadow index of blindfolded compound eyes with wild-type gravid mosquitoes. by Si Yu Zhao (19544793)

    Published 2024
    Save to List
    Saved in:
  13. 8573
    IFN-γ is produced by microglia, CD4<sup>+</sup> T cells, and macrophages in the brains of JHMV infected mice.

    IFN-γ is produced by microglia, CD4<sup>+</sup> T cells, and macrophages in the brains of JHMV infected mice. by Catherine M. Kerr (21492574)

    Published 2025
    Save to List
    Saved in:
  14. 8574
    Point spread functions of intraocular lenses at different vergences.

    Point spread functions of intraocular lenses at different vergences. by Deniz Akyazi (19935162)

    Published 2024
    “…<p>For each IOL, reading charts were captured using the artificial eye model. Resulting PSFs point out that monofocal IOL has a constantly decreasing focus starting from 0D towards -5D. …”
    Save to List
    Saved in:
  15. 8575
    Comparison of dynamic mechanical properties of non-superheated and superheated A357 alloys

    Comparison of dynamic mechanical properties of non-superheated and superheated A357 alloys by Mazlee Mohd Noor (2582818)

    Published 2017
    Save to List
    Saved in:
  16. 8576
    RNAseq analysis of IAV-infected AECs and AMs with and without TrkA inhibition.

    RNAseq analysis of IAV-infected AECs and AMs with and without TrkA inhibition. by Vikram Verma (13822961)

    Published 2022
    Save to List
    Saved in:
  17. 8577
    image2_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif

    image2_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif by Hui-Min Liu (3323370)

    Published 2021
    “…Notably, we observed that miR-18a-5p was remarkably increased in CML cells. Treating CML cells with leonurine significantly decreased miR-18a-5p expression. …”
    Save to List
    Saved in:
  18. 8578
    image1_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif

    image1_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif by Hui-Min Liu (3323370)

    Published 2021
    “…Notably, we observed that miR-18a-5p was remarkably increased in CML cells. Treating CML cells with leonurine significantly decreased miR-18a-5p expression. …”
    Save to List
    Saved in:
  19. 8579
    image3_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif

    image3_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif by Hui-Min Liu (3323370)

    Published 2021
    “…Notably, we observed that miR-18a-5p was remarkably increased in CML cells. Treating CML cells with leonurine significantly decreased miR-18a-5p expression. …”
    Save to List
    Saved in:
  20. 8580
    image4_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif

    image4_Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.tif by Hui-Min Liu (3323370)

    Published 2021
    “…Notably, we observed that miR-18a-5p was remarkably increased in CML cells. Treating CML cells with leonurine significantly decreased miR-18a-5p expression. …”
    Save to List
    Saved in:

Search Tools: